164 related articles for article (PubMed ID: 16895675)
1. [Influence of hemodialysis on total and free malondialdehyde measured by a new HPLC method].
Steghens JP; Combarnous F; Arkouche W; Flourie F; Hadj-Aissa A
Nephrol Ther; 2005 May; 1(2):121-5. PubMed ID: 16895675
[TBL] [Abstract][Full Text] [Related]
2. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
[TBL] [Abstract][Full Text] [Related]
3. The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients.
Valentini J; Grotto D; Paniz C; Roehrs M; Burg G; Garcia SC
Biomed Pharmacother; 2008; 62(6):378-82. PubMed ID: 18166291
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
7. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
[TBL] [Abstract][Full Text] [Related]
8. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
Hultqvist M; Hegbrant J; Nilsson-Thorell C; Lindholm T; Nilsson P; Lindén T; Hultqvist-Bengtsson U
Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
[TBL] [Abstract][Full Text] [Related]
10. No increase of plasma malondialdehyde after primary coronary angioplasty for acute myocardial infarction.
Olsson KA; Harnek J; Ohlin AK; Pavlidis N; Thorvinger B; Ohlin H
Scand Cardiovasc J; 2002 Aug; 36(4):237-40. PubMed ID: 12201972
[TBL] [Abstract][Full Text] [Related]
11. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
Shi XF; Ding F; Zhu QY; Xue J; Lu FM; Gu Y; Lin ST
Ren Fail; 2005; 27(2):213-9. PubMed ID: 15807188
[TBL] [Abstract][Full Text] [Related]
12. Association of plasma adiponectin levels with oxidative stress in hemodialysis patients.
Lim PS; Chen SL; Wu MY; Hu CY; Wu TK
Blood Purif; 2007; 25(4):362-9. PubMed ID: 17709916
[TBL] [Abstract][Full Text] [Related]
13. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
[TBL] [Abstract][Full Text] [Related]
14. [Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease].
Terrier-Lenglet A; Nollet A; Liabeuf S; Barreto DV; Brazier M; Lemke HD; Vanholder R; Choukroun G; Massy ZA;
Nephrol Ther; 2011 Jul; 7(4):219-24. PubMed ID: 21316322
[TBL] [Abstract][Full Text] [Related]
15. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
16. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
17. Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection.
Grotto D; Santa Maria LD; Boeira S; Valentini J; Charão MF; Moro AM; Nascimento PC; Pomblum VJ; Garcia SC
J Pharm Biomed Anal; 2007 Jan; 43(2):619-24. PubMed ID: 16949242
[TBL] [Abstract][Full Text] [Related]
18. [Levels of serum ascorbate and its metabolites in hemodialysis patients].
Hirano H; Tone Y; Otani H; Oya M; Kimura K; Saika Y; Fujii R; Mune M; Ichinose M; Yukawa S
Nihon Jinzo Gakkai Shi; 2004 Jul; 46(5):426-33. PubMed ID: 15446598
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances].
Lefèvre G; Beljean-Leymarie M; Beyerle F; Bonnefont-Rousselot D; Cristol JP; Thérond P; Torreilles J
Ann Biol Clin (Paris); 1998; 56(3):305-19. PubMed ID: 9754263
[TBL] [Abstract][Full Text] [Related]
20. A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS). A comparison with a commercially available kit.
Seljeskog E; Hervig T; Mansoor MA
Clin Biochem; 2006 Sep; 39(9):947-54. PubMed ID: 16781699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
